Aerwave Medical develops an alternative to traditional medications used to treat COPD and asthma.
Aerwave Medical has raised $12.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Aerwave Medical's investors include Lucius Partners.
Aerwave Medical is headquartered in New York, United States.
Aerwave Medical develops an alternative to traditional medications used to treat COPD and asthma.
Aerwave Medical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aerwave Medical — Funding & Investors." VCBacked, January 8, 2025, https://www.vcbacked.co/company/aerwave-medical. Accessed August 18, 2026.
VCBacked. (2025). Aerwave Medical — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/aerwave-medical
{{cite web |title=Aerwave Medical — Funding & Investors |url=https://www.vcbacked.co/company/aerwave-medical |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated